Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05066321 · ClinicalTrials.gov registry record · NA
Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05066321: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT05066321 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05066321, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
In this pilot single-armed open-label intervention study of up to 20 individuals with moderate to severe Opioid Use Disorder (OUD)organized into two consecutive groups of up to 10 individuals each, the investigators will measure addiction outcomes and the acceptability and feasibility of adding Mindfulness Oriented Recovery Enhancement (MORE), a promising mind-body therapy to gold standard in-hospital addiction consultation among hospitalized individuals with OUD in advance of a planned two-arm pilot randomized controlled trial.
Interventions
- BEHAVIORAL Mindfulness Oriented Recovery Enhancement Sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-18 |
| Est. Completion | 2023-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05066321
The ClinicalTrials.gov registry entry for NCT05066321 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness Oriented Recovery Enhancement Sessions is the first listed.
NCT05066321 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05066321 about?
NCT05066321 is a clinical study titled "Mindfulness Oriented Recovery Enhancement in Hospitalized People With Opioid Use Disorder". In this pilot single-armed open-label intervention study of up to 20 individuals with moderate to severe Opioid Use Disorder (OUD)organized into two consecutive groups of up to 10 individuals each, the investigators will measure addiction outcomes and the acceptability and feasibility of adding Mind...
What is the current status of trial NCT05066321?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-18. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT05066321?
The interventions under investigation include: Mindfulness Oriented Recovery Enhancement Sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05066321?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.